CCO.AX The Calmer Co (ASX) 03 Feb 2026 intraday: CCO.AX stock earnings metrics to watch

CCO.AX stock trades at A$0.0045 intraday as investors prepare for an earnings release on 06 Feb 2026. We flag key numbers ahead of the report: EPS -0.01, market cap A$13,762,590, and recent volume of 1,374,829 shares. This earnings spotlight looks at valuation, technicals, and short-term catalysts that could move shares in the ASX Australia market.

CCO.AX stock intraday snapshot

Today CCO.AX stock is unchanged at A$0.0045 with a day low of A$0.0040 and day high of A$0.0045. Volume sits at 1,374,829 versus an average volume of 3,463,287, highlighting thin liquidity. Market cap is A$13,762,590, marking CCO.AX as a microcap on the ASX in Australia.

CCO.AX stock earnings outlook

The Calmer Co will report earnings after the market on 06 Feb 2026; investors should watch revenue, gross margin and cash flow. Last reported EPS was -0.01 and the trailing PE is negative at -0.45, indicating operating losses. Management commentary on US and Fiji distribution, plus inventory levels, will be the immediate catalysts for the stock.

CCO.AX stock financials and valuation

On valuation metrics CCO.AX shows price to sales 1.71 and price to book 6.48, signaling a premium to book value despite losses. Debt to equity is 1.21 and current ratio is 1.97, showing the company has short-term coverage but elevated leverage. Gross profit margin is 43.33% while net margin is negative at -49.69%, reflecting the small scale and product mix in packaged foods.

CCO.AX stock technicals and trading

Technical indicators on CCO.AX stock are mixed: RSI 51.11 and ADX 22.90 suggest neutral momentum. The 50-day average price is A$0.00382 and the 200-day average is A$0.00359, both below the current price, showing a modest uptrend over months. Low liquidity and high average volume variance increase short-term volatility for active traders.

CCO.AX stock risks and catalysts

Key risks for CCO.AX stock include continued negative EPS, limited free cash flow, and concentrated markets in Fiji and the US. Catalysts include stronger US retail listings, new product rollouts, and positive cash flow from online sales. Regulatory review of medicinal kava in export markets remains a downside risk that could quickly affect price.

CCO.AX stock Meyka grade and forecast

Meyka AI rates CCO.AX with a score out of 100: 68.59 (Grade B, Suggestion HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects A$0.00043 for the next year versus the current price of A$0.0045, implying an ~90.52% downside; forecasts are model-based projections and not guarantees. Reasonable price targets we track are a conservative A$0.0020 and a bullish A$0.0070, framed as scenario levels rather than firm recommendations.

Final Thoughts

Earnings due 06 Feb 2026 place CCO.AX stock in a high-attention window while trading microcap dynamics. The Calmer Co (CCO.AX) shows improving short-term price momentum versus its 50-day and 200-day averages, but fundamentals remain stretched: EPS -0.01, PB 6.48, and negative operating margins. Meyka AI’s forecast model projects A$0.00043 versus the current A$0.0045, implying an estimated -90.52% move; this highlights the model’s view that the share price could face large downside absent positive earnings or operational developments. Traders should weigh thin liquidity, sector comparatives in consumer defensive packaged foods, and upcoming management commentary. We view the company as a speculative hold ahead of results, with upside tied to clearer revenue traction in the United States and tighter inventory conversion. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.